July 19, 2022
U.S. Patent to Protect Buprenorphine Production Process
Press Releases
River Stone Biotech Inc. Announces Issuance of U.S. Patent to Protect Their More Efficient Buprenorphine Production Process. Jul. 19, 2022 – River Stone Biotech Inc.(RSB), a synthetic biology business centered […]
April 22, 2022
River Stone Biotech Inc. participates in DCAT 2022 conference
Press Releases
River Stone Biotech Inc. participates in DCAT 2022 conference and announces its ambition in becoming a global provider of substance abuse APIs. Cambridge, April 28, 2022 – River Stone Biotech […]
November 10, 2021
Series B Fundraise Closes
Press Releases
River Stone Biotech Inc. Announces $6.8M Series B Financing to Advance Lead Pipeline Projects To Treat Opiate Use Disorder and Opiate Overdose
November 10, 2021
$6.8M Series B Financing to Advance Lead Pipeline Projects
Press Releases
River Stone Biotech Inc. Announces $6.8M Series B Financing to Advance Lead Pipeline Projects To Treat Opiate Use Disorder and Opiate Overdose Cambridge, Nov. 10, 2021 – River Stone Biotech […]